glp-1 alabama Injections in (AL) π Appetite suppressants and GLP-1
Description
2015 Feb;26(2):589-99
Taha MB, Yahya T, Satish P, et al
"We believe retatrutide could become an important option for patients with significant weight loss needs and certain complications." Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks
Your physician can help balance efficacy goals with tolerability
